Evidence mapPaperPMID 40124930Full record

ArticleClinical, cosmetic and investigational dermatology2025

Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata.

Ghadah Alhetheli, Mohammed Saleh Al-Dhubaibi, Saleh Salem Bahaj, Sharif Alhajlah, Ahmed Ibrahim AbdElneam

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ghadah AlhetheliDepartment of Dermatology, College of Medicine, Qassim University, Buraydah, Saudi Arabia.ORCID 0000-0002-3896-1873
Mohammed Saleh Al-DhubaibiDepartments of Dermatology, College of Medicine, Shaqra University, Dawadmi, Saudi Arabia.ORCID 0000-0002-6418-6647
Saleh Salem BahajDepartment of Microbiology and Immunology, Faculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen.ORCID 0000-0001-6582-907X
Sharif AlhajlahDepartment of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra, 11961, Saudi Arabia.
Ahmed Ibrahim AbdElneamDepartment of Clinical Biochemistry, Department of Basic Medical Sciences, College of Medicine, Shaqra University, Dawadmi, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alopecia areata (AA), is a common autoimmune nonscarring alopecia. Vitamin D is involved in various biological processes such as immune regulation, cellular growth, and specialization, as well as the maintenance of the hair cycle. We aimed to explore the impact of different Tru9I variant genotypes on serum vitamin D levels and vitamin D receptor (VDR) gene expression. Methods: Case-control study that included 72 individuals diagnosed with AA, along with age and sex matched healthy controls of 72 individuals. Blood samples were obtained to measure Vitamin D level and VDR gene expression focusing on Tru9I variant genotypes. Results: Our findings indicate, for the first time, a possible association between the "U" allele and low vitamin D levels, along with altered activity of the VDR gene as observed in patients with AA. Conclusion: This suggests a complex causal relationship between genetic factors and vitamin D in AA. Interestingly, "u" allele was found to be significantly more prevalent in the healthy control group than in the patients group, raising the possibility of its protective mechanism against the development of this disease in healthy individuals.

Indexed as

alopecia areataTru9I variantVDR gene expressionvitamin D

Identifiers

PMID40124930
PMCPMC11927502

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.